Oriflame shares new scientific data on Oripeptide-3
Oriflame has announced new scientific findings around Oripeptide-3, its patented bioactivating technology and the core of the NovAge+ skincare range. According to the company, new data shows that Oripeptide-3 directly supports skin health and age. Developed over nearly two decades, Oripeptide-3 is designed to work in alignment with the skin’s natural biological processes. The technology aims to support the skin’s functional lifespan by strengthening markers linked to repair, resilience, and vitality.
The research highlights that Oripeptide-3 targets five recognised hallmarks of skin ageing, including cellular reactivation, DNA protection, protein quality maintenance, oxidative stress reduction, and improved cellular energy. These mechanisms support skin renewal, firmness, clarity, and overall function, forming the scientific foundation of the NovAge+ range.
The findings reflect Oriflame’s continued research into skin longevity, cellular health, and ageing, with a focus on addressing skin concerns at a molecular and cellular level, not just surface outcomes.
Global collagen market is set to boom as demand expands across beauty
The global collagen market was valued at USD 10,376.1 million in 2024 and is projected to reach USD 26,213.0 million by 2033, growing at a CAGR of 11.0 per cent between 2025 and 2033. Collagen continues to play a significant role in the beauty industry due to its link with skin elasticity, firmness, and overall skin health.
Bovine collagen held the largest market share at 35.3 per cent in 2024, driven by its wide availability and use across beauty supplements, ingestible skincare, and cosmetic formulations. It’s a commonly used ingredient for skin-and joint-related beauty products.
Marine collagen is the fastest growing at a CAGR of 11.9 per cent during the forecast period. Its higher bioavailability has increased its use in premium beauty, anti-ageing, and nutricosmetic products, particularly as demand for sustainably sourced ingredients grows.
Hydrolysed collagen is also seeing rapid adoption, with a projected CAGR of 11.5 per cent. Its improved absorption supports its use in skin, hair, and nail-focused beauty and wellness products.
EU updates CMR List, banning 15 cosmetic ingredients and reviewing four more
The European Union has updated its list of substances classified as carcinogenic, mutagenic, or toxic for reproduction (CMR), adding 15 banned ingredients and two restricted ones. The amendment entered into force on February 2, 2026, with mandatory compliance for beauty and personal care companies across the EU by May 1, 2026.
In parallel, the European Chemicals Agency (ECHA) has released proposals for the harmonised classification and labelling of four cosmetic ingredients: maleic acid, ammonium vanadate, 1,4-butanediol, and dimethyl imidazolidinone. These substances are currently used in cosmetics for functions such as pH adjustment, solvent action, skin and hair conditioning, and moisturisation.
According to ECHA, the primary health concerns linked to these ingredients arise through ingestion, eye contact, or prolonged exposure, including absorption. The proposals are now under review and could lead to further regulatory action, depending on the final classification outcomes.